Martin, Christopher T.
Criego, Amy B.
Carlson, Anders L.
Bergenstal, Richard M.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (UC4DK108611, UC4DK108611)
Article History
First Online: 27 June 2019
Compliance with Ethical Standards
:
: Christopher T. Martin reports consulting fees and stock from MicroOptx Inc. In addition, he is co-inventor of patent US20180333085A1 “Aqueous humor monitoring devices and methods” pending to MicroOptx Inc.Amy B. Criego reports grants and other from Abbott Diabetes Care, other from Eli Lilly, grants from Medtronic, other from Senseonics, and grants from DexCom.Anders L. Carlson is employed by HealthPartners Institute/Park Nicollet Health Services and they have contracts with Abbott, Medtronic, Dexcom, Novo Nordisk, Sanofi, and Insulet for his services as a research investigator and/or consultant. No personal income from any of these services goes to Anders L. Carlson.Richard M. Bergenstal has received research support, consulted, or has been on the scientific advisory board for Abbott Diabetes Care, DexCom, Hygieia, Johnson & Johnson, Eli Lilly, Medtronic, Novo Nordisk, Onduo, Roche, Sanofi, Senseonics, and United Healthcare. His employer, non-profit HealthPartners Institute, contracts for his services and no personal income goes to Richard M. Bergenstal.
: This article does not contain any studies with human or animal subjects performed by any of the authors.